ENTITY
Lupin Ltd

Lupin Ltd (LPC IN)

165
Analysis
Health CareIndia
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
more
02 Sep 2023 08:51Broker

Axis Top Picks for the month of September 2023

Axis Top Picks basket delivered impressive returns of 28% in the last one year, against the 8% return posted by Nifty 50, beating the benchmark by...

Logo
408 Views
Share
24 Aug 2023 09:42Broker

Top Sector Ideas - Pharma

In Q1FY24, the Pharma Coverage universe posted robust revenue growth of 20.5%/6.1% YoY/QoQ on account of volume rampup, new launches (especially...

Logo
332 Views
Share
bullishLupin Ltd
07 Aug 2023 21:27Broker

LUPIN Ltd - Positive Outlook Backed by the Launch of Niche Products

The company’s sales were up 28.6% YoY at Rs 4,330 Cr, and the growth was majorily led by its India business (+9.8% YoY), EMEA (+19.6% YoY)

Logo
272 Views
Share
03 Aug 2023 08:25Broker

Axis Top Picks - Aug 2023

The Axis Top Picks Basket returned a solid return of 10% in July’23 against the 3% return posted by Nifty 50, beating the benchmark by a wide margin.

Logo
243 Views
Share
02 Aug 2023 07:52Broker

Axis Top Picks - Aug 2023

The Axis Top Picks Basket returned a solid return of 10% in July’23 against the 3% return posted by Nifty 50, beating the benchmark by a wide margin.

Logo
199 Views
Share
x